Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 0.91% | $102.52M | $415.03B | 49.62% | 81 Outperform | |
| Roche Holding AG | 0.86% | $97.50M | CHF253.28B | 42.40% | 73 Outperform | |
| Shell | 0.78% | $87.42M | $205.20B | 13.83% | 78 Outperform | |
| HSBC Holdings | 0.75% | $84.51M | $255.38B | 54.20% | 78 Outperform | |
| Novartis | 0.65% | $73.49M | $252.28B | 34.78% | 80 Outperform | |
| Celestica | 0.65% | $72.84M | $35.26B | 209.56% | 76 Outperform | |
| SAFRAN SA | 0.57% | $63.91M | €121.40B | 39.76% | 67 Neutral | |
| UBS Group AG | 0.55% | $62.20M | $134.75B | 35.62% | ― | |
| Toyota Motor | 0.53% | $59.23M | $273.03B | 19.44% | 81 Outperform | |
| TotalEnergies SE | 0.51% | $57.83M | €119.91B | 4.50% | 78 Outperform |